tiprankstipranks
Trending News
More News >
Modern Dental Group Limited (HK:3600)
:3600

Modern Dental Group Limited (3600) AI Stock Analysis

Compare
6 Followers

Top Page

HK:3600

Modern Dental Group Limited

(3600)

Select Model
Select Model
Select Model
Outperform 74 (OpenAI - 4o)
Rating:74Outperform
Price Target:
HK$4.50
▼(-17.13% Downside)
Modern Dental Group's strong financial performance and reasonable valuation are the primary drivers of its stock score. The absence of recent cash flow data is a concern, but the company's solid revenue growth and profitability provide a stable foundation. Technical indicators show moderate strength, supporting a positive outlook.
Positive Factors
Revenue Growth
Consistent revenue growth indicates a positive trajectory, suggesting strong demand for Modern Dental's products and services, which supports long-term business sustainability.
Profitability
High profit margins reflect efficient operations and pricing power, which enhance the company's ability to reinvest in growth and withstand competitive pressures.
Balance Sheet Health
A strong equity base and moderate leverage indicate financial stability, providing the company with flexibility to pursue strategic opportunities without excessive risk.
Negative Factors
Cash Flow Reporting
The absence of recent cash flow data raises concerns about liquidity management, which could impact the company's ability to fund operations and growth initiatives.
EBIT Consistency
Inconsistent EBIT performance may indicate volatility in operational efficiency, which could affect profitability and investor confidence over time.
Cash Management Concerns
Uncertainty in cash management could hinder the company's ability to maintain operational efficiency and meet financial obligations, posing a risk to long-term stability.

Modern Dental Group Limited (3600) vs. iShares MSCI Hong Kong ETF (EWH)

Modern Dental Group Limited Business Overview & Revenue Model

Company DescriptionModern Dental Group Limited, an investment holding company, engages in production and distribution of dental prosthetic devices in Europe, Greater China, North America, Australia, and internationally. It operates through three segments: Fixed Prosthetic Devices, Removable Prosthetic Devices, and Others. The Fixed Prosthetic Devices segment offers restorative dental procedures, such as crowns, bridges, and implant. The Removable Prosthetic Devices segment produces full and partial dentures with and without metal frameworks. The Others segment offers orthodontic devices, sports guards, anti-snoring devices, raw materials, and dental equipment. This segment also provides services for educational events and seminars. The company sells its products to dentists, dental clinics, hospitals, distributors, and other customers under the Permadental & Semperdent, Schmidt, Apex Digital Dental, Elysee, Labocast, Modern Dental Laboratory, Yangzhijing, Southern Cross Dental, Andent, Modern Dental USA, Sundance Dental, Quantum Dental, TrioClear, and Digitek Dental brands. Modern Dental Group Limited was founded in 1986 and is based in Kowloon, Hong Kong.
How the Company Makes MoneyModern Dental Group Limited generates revenue through multiple streams, primarily from the sale of dental prosthetics and related products to dental practices and healthcare providers. The company operates a direct sales model, supplying high-quality dental products and equipment, which accounts for a significant portion of its income. Additionally, it earns revenue through laboratory services, offering custom solutions and products tailored to specific client needs. The company may also engage in partnerships with dental clinics and healthcare organizations, enhancing its market reach and facilitating bulk sales. Furthermore, Modern Dental Group benefits from ongoing relationships with suppliers and distributors, which can lead to favorable pricing and increased sales volume, ultimately contributing to its overall earnings.

Modern Dental Group Limited Financial Statement Overview

Summary
Modern Dental Group shows strong financial performance with robust revenue growth and profitability. The income statement is solid, but the absence of recent cash flow data is a concern that needs addressing to ensure liquidity.
Income Statement
Modern Dental Group has demonstrated a strong income statement performance with a consistent increase in total revenue over recent years. The company reported a gross profit margin of approximately 53.5% for the most recent period, and the net profit margin stands at around 12.1%. Both EBIT and EBITDA margins are solid at 15.9% and 19.8%, respectively. The revenue growth rate from 2023 to 2024 was about 6.06%, indicating a positive growth trajectory. Overall, the income statement reflects strong profitability and growth, though there is room for improvement in EBIT consistency.
Balance Sheet
The balance sheet of Modern Dental Group shows a stable financial position with a debt-to-equity ratio of approximately 0.34, indicating moderate leverage. The return on equity (ROE) for the latest period is about 15.0%, which is robust and demonstrates effective management of equity. The equity ratio is a strong 66.7%, highlighting a solid equity base relative to assets. While the company's leverage is under control, continuous monitoring is advised to maintain this stability.
Cash Flow
The cash flow analysis for Modern Dental Group reveals some challenges, particularly with the reporting of operating cash flow and free cash flow being zero for the most recent period. Historically, the company has shown positive free cash flow growth, and the operating cash flow to net income ratio was healthy in previous years. However, the lack of cash flow data for the latest period raises concerns about cash management, which needs addressing to ensure liquidity and operational efficiency.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue3.50B3.36B3.17B2.83B2.96B2.19B
Gross Profit1.89B1.80B1.70B1.38B1.55B1.09B
EBITDA731.58M719.12M696.64M464.09M627.01M295.21M
Net Income478.00M408.00M404.10M220.46M360.82M107.76M
Balance Sheet
Total Assets4.40B4.07B3.95B3.54B3.66B3.67B
Cash, Cash Equivalents and Short-Term Investments595.26M816.83M697.69M447.72M638.00M746.71M
Total Debt768.60M924.22M852.20M788.19M833.09M1.03B
Total Liabilities1.33B1.35B1.31B1.21B1.30B1.41B
Stockholders Equity2.99B2.72B2.63B2.32B2.35B2.25B
Cash Flow
Free Cash Flow487.63M379.37M416.04M53.36M369.27M303.87M
Operating Cash Flow579.73M521.19M575.76M238.72M510.72M376.32M
Investing Cash Flow-298.13M-145.47M-154.96M-227.55M-142.65M-47.32M
Financing Cash Flow-398.21M-227.70M-173.64M-201.79M-452.12M-32.95M

Modern Dental Group Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price5.43
Price Trends
50DMA
5.29
Negative
100DMA
5.32
Negative
200DMA
4.68
Positive
Market Momentum
MACD
0.03
Positive
RSI
44.85
Neutral
STOCH
40.63
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3600, the sentiment is Negative. The current price of 5.43 is above the 20-day moving average (MA) of 5.40, above the 50-day MA of 5.29, and above the 200-day MA of 4.68, indicating a neutral trend. The MACD of 0.03 indicates Positive momentum. The RSI at 44.85 is Neutral, neither overbought nor oversold. The STOCH value of 40.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:3600.

Modern Dental Group Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
HK$4.93B10.3917.42%3.65%6.87%18.37%
74
Outperform
HK$1.90B12.323.76%7.46%21.39%-0.57%
72
Outperform
HK$26.13B45.2224.57%0.63%13.58%24.59%
70
Neutral
HK$5.46B26.3710.31%14.06%3.02%
56
Neutral
HK$11.41B
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:3600
Modern Dental Group Limited
5.28
1.51
40.16%
HK:1358
PW Medtech Group Ltd.
1.29
0.42
47.43%
HK:1501
Shanghai Kindly Medical Instruments Co., Ltd. Class H
31.00
3.95
14.60%
HK:2276
Shanghai Conant Optical Co. Ltd. Class H
54.45
30.06
123.25%
HK:6699
Angelalign Technology Inc.
66.80
15.04
29.06%

Modern Dental Group Limited Corporate Events

Modern Dental Group Announces Board Changes with Director Retirement
Dec 12, 2025

Modern Dental Group Limited announced the retirement of Dr. Cheung Wai Man William as an independent non-executive director, effective December 15, 2025, as he intends to focus on other commitments. Following his departure, Dr. Yau Ka Po will assume the roles of chairman of the remuneration committee and member of the nomination committee, indicating a strategic shift in the company’s board composition.

The most recent analyst rating on (HK:3600) stock is a Buy with a HK$4.50 price target. To see the full list of analyst forecasts on Modern Dental Group Limited stock, see the HK:3600 Stock Forecast page.

Modern Dental Group Updates Board of Directors
Dec 12, 2025

Modern Dental Group Limited has announced an updated list of its board of directors, effective from December 15, 2025. The board comprises executive directors including Dr. Ronald Yik Long Chan as Chairman and CEO, and Ms. Yik Yu Chan as Chief Marketing Officer, among others. The company also has non-executive and independent non-executive directors. The board oversees three committees: Audit, Nomination, and Remuneration, each chaired by different members. This announcement reflects the company’s commitment to structured governance and strategic leadership, which may influence its operational efficiency and stakeholder confidence.

The most recent analyst rating on (HK:3600) stock is a Buy with a HK$4.50 price target. To see the full list of analyst forecasts on Modern Dental Group Limited stock, see the HK:3600 Stock Forecast page.

Modern Dental Group Announces Change in Controlling Shareholder Structure
Dec 5, 2025

Modern Dental Group Limited announced a change in the shareholding structure of its controlling shareholder, Triera Holdings Limited. On December 5, 2025, Mr. Chan Kwun Fung transferred 50% of Triera’s issued share capital to CKF Family Limited as part of family planning and succession arrangements. Despite the transfer, Mr. Chan Kwun Fung and Mr. Chan Kwun Pan continue to act in concert regarding the company’s shares. The transfer triggered an obligation for a mandatory general offer under the Takeovers Code, but a waiver was granted by the Securities and Futures Commission.

The most recent analyst rating on (HK:3600) stock is a Buy with a HK$4.50 price target. To see the full list of analyst forecasts on Modern Dental Group Limited stock, see the HK:3600 Stock Forecast page.

Modern Dental Group Grants Share Options to Recognize Employee Contributions
Nov 28, 2025

Modern Dental Group Limited announced the grant of 23,250,000 share options to its directors and employees as part of its share option scheme. This initiative is aimed at recognizing the past performance and contributions of the grantees, as well as their potential future contributions to the company, thereby aligning their interests with the company’s long-term growth objectives.

The most recent analyst rating on (HK:3600) stock is a Buy with a HK$4.50 price target. To see the full list of analyst forecasts on Modern Dental Group Limited stock, see the HK:3600 Stock Forecast page.

Modern Dental Group Achieves Record Revenue Amid Digital Transformation
Nov 27, 2025

Modern Dental Group Limited reported a record revenue increase of approximately 9.2% for the nine months ending September 30, 2025, despite a challenging macro-economic environment. The company’s strategic focus on digital transformation and operational efficiency has allowed it to outperform industry peers and capitalize on emerging opportunities, particularly in Europe and through acquisitions like Hexa Ceram.

The most recent analyst rating on (HK:3600) stock is a Buy with a HK$4.50 price target. To see the full list of analyst forecasts on Modern Dental Group Limited stock, see the HK:3600 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 23, 2025